Quick Answer
MEDICINOVA INC reported Cash and Equivalents of $30.81 million for fiscal year 2025.
MEDICINOVA INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $30.81M | -23.7% |
| 2024 | $40.36M | -20.9% |
| 2023 | $51.00M | +175.6% |
| 2022 | $18.51M | -74.1% |
| 2021 | $71.43M | +19.0% |
| 2020 | $60.04M | -5.9% |
| 2019 | $63.79M | +2.4% |
| 2018 | $62.31M | +122.6% |
| 2017 | $27.99M | +16.1% |
| 2016 | $24.12M | +9.2% |
| 2015 | $22.08M | +89.2% |
| 2014 | $11.67M | +74.2% |
| 2013 | $6.70M | +67.1% |
| 2012 | $4.01M | -73.4% |
| 2011 | $15.09M | -46.6% |
| 2010 | $28.25M | +46.8% |
| 2009 | $19.24M | -0.3% |
| 2008 | $19.30M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.56M | -23.0% | -5.0% |
| June 30, 2025 | $34.26M | -22.7% | -6.3% |
| March 31, 2025 | $36.57M | -22.4% | -9.4% |
| December 31, 2024 | $40.36M | -20.9% | -4.5% |
| September 30, 2024 | $42.28M | -17.9% | -4.6% |
| June 30, 2024 | $44.34M | -16.1% | -5.9% |
| March 31, 2024 | $47.14M | -14.7% | -7.6% |
| December 31, 2023 | $51.00M | +175.6% | -1.0% |
- MEDICINOVA INC showed a decrease of -23.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, MEDICINOVA INC’s cash and equivalents has grown by 59.6% (from $19.30 million to $30.81 million).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: